Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.85 EUR | -3.24% | +9.52% | -20.48% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Sales 2024 * | 59.32M 63.78M | Sales 2025 * | 75.02M 80.65M | Capitalization | 792M 851M |
---|---|---|---|---|---|
Net income 2024 * | -16M -17.2M | Net income 2025 * | - 0 | EV / Sales 2024 * | 12.8 x |
Net cash position 2024 * | 32.3M 34.72M | Net cash position 2025 * | 51.53M 55.4M | EV / Sales 2025 * | 9.87 x |
P/E ratio 2024 * |
-42.7
x | P/E ratio 2025 * |
-328
x | Employees | 238 |
Yield 2024 * |
-
| Yield 2025 * |
0.54% | Free-Float | 42.17% |
1 day | -3.24% | ||
1 week | +9.52% | ||
Current month | +9.52% | ||
1 month | -2.50% | ||
3 months | -8.28% | ||
6 months | -27.07% | ||
Current year | -20.48% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 16-09-30 |
Enno Spillner
DFI | Director of Finance/CFO | 55 | 23-03-31 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olaf Stiller
FOU | Founder | 47 | 06-12-31 |
Peter Wendeln
BRD | Director/Board Member | 59 | - |
Klaus Röhrig
BRD | Director/Board Member | 47 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 17 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 44.85 | -3.24% | 8,311 |
24-05-06 | 46.35 | +7.29% | 15,704 |
24-05-03 | 43.2 | +5.37% | 25,965 |
24-05-02 | 41 | +0.12% | 7,942 |
24-04-30 | 40.95 | -1.56% | 15,180 |
Delayed Quote Xetra, May 07, 2024 at 11:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.48% | 882M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- FYB Stock